Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST-D (Biochemical Efficacy and Safety Trial of Vitamin D)
Overview
Authors
Affiliations
Background: The relevance of vitamin D for prevention of cardiovascular disease is uncertain. The BEST-D (Biochemical Efficacy and Safety Trial of vitamin D) trial previously reported effects of vitamin D on plasma markers of vitamin D status, and the present report describes the effects on blood pressure, heart rate, arterial stiffness, and cardiac function.
Methods And Results: This was a randomized, double-blind, placebo-controlled trial of 305 older people living in United Kingdom, who were allocated vitamin D 4000 IU (100 μg), vitamin D 2000 IU (50 μg), or placebo daily. Primary outcomes were plasma concentrations of 25-hydroxy-vitamin D and secondary outcomes were blood pressure, heart rate, and arterial stiffness in all participants at 6 and 12 months, plasma N-terminal prohormone of brain natriuretic peptide levels in all participants at 12 months, and echocardiographic measures of cardiac function in a randomly selected subset (n=177) at 12 months. Mean (SE) plasma 25-hydroxy-vitamin D concentrations were 50 (SE 2) nmol/L at baseline and increased to 137 (2.4), 102 (2.4), and 53 (2.4) nmol/L after 12 months in those allocated 4000 IU/d, 2000 IU/d of vitamin D, or placebo, respectively. Allocation to vitamin D had no significant effect on mean levels of blood pressure, heart rate, or arterial stiffness at either 6 or 12 months, nor on any echocardiographic measures of cardiac function, or plasma N-terminal prohormone of brain natriuretic peptide concentration at 12 months.
Conclusions: The absence of any significant effect of vitamin D on blood pressure, arterial stiffness, or cardiac function suggests that any beneficial effects of vitamin D on cardiovascular disease are unlikely to be mediated through these mechanisms.
Clinical Trial Registration: URL: https://www.clinicaltrialsregister.eu/ctr-search/search. Unique identifier: EudraCT number: 2011-005763-24a.
Blood Pressure Decreases in Overweight Elderly Individuals on Vitamin D: A Randomized Trial.
Rahme M, Al-Shaar L, Tamim H, Fuleihan G J Endocr Soc. 2024; 8(12):bvae168.
PMID: 39534319 PMC: 11555685. DOI: 10.1210/jendso/bvae168.
Kujawska A, Bromage S, Simoes J, Zupkauskiene J, McMahon N, Zalewski P Heliyon. 2024; 10(4):e25615.
PMID: 38380006 PMC: 10877265. DOI: 10.1016/j.heliyon.2024.e25615.
Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?.
Vervloet M Clin Kidney J. 2023; 16(11):1766-1775.
PMID: 37915898 PMC: 10616505. DOI: 10.1093/ckj/sfad112.
Behers B, Melchor J, Behers B, Meng Z, Swanson P, Paterson H Nutrients. 2023; 15(19).
PMID: 37836507 PMC: 10574336. DOI: 10.3390/nu15194223.
Wu H, Chen J J Pers Med. 2022; 12(11).
PMID: 36579481 PMC: 9694699. DOI: 10.3390/jpm12111768.